Novo Nordisk
NVO
#105
Rank
A$233.84 B
Marketcap
A$52.28
Share price
-1.52%
Change (1 day)
-54.46%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): A$32.20 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$47.70 Billion. , an increase over its 2024 earnings that were of A$28.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 A$30.16 B6.28%
2024 A$28.37 B28.01%
2023 A$22.17 B57.81%
2022 A$14.04 B5.24%
2021 A$13.34 B12.38%
2020 A$11.87 B13.11%
2019 A$10.50 B-3.45%
2018 A$10.87 B1.88%
2017 A$10.67 B4.3%
2016 A$10.23 B10.32%
2015 A$9.27 B7.47%
2014 A$8.63 B3.4%
2013 A$8.34 B19.09%
2012 A$7.01 B15.58%
2011 A$6.06 B16.58%
2010 A$5.20 B25.66%
2009 A$4.14 B10.68%
2008 A$3.74 B55.82%
2007 A$2.40 B7.02%
2006 A$2.24 B19.05%
2005 A$1.88 B10.55%
2004 A$1.70 B
2002 A$1.17 B-14.39%
2001 A$1.36 B-52.82%
2000 A$2.90 B250%
1999 A$0.82 B31.21%
1998 A$0.63 B34.31%
1997 A$0.47 B11.46%
1996 A$0.42 B9.03%
1995 A$0.38 B-3.15%
1994 A$0.39 B-0.67%
1993 A$0.40 B45.38%
1992 A$0.27 B-13.81%
1991 A$0.32 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.14 B-0.9%
1986 A$0.15 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.66 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.02 B 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.07 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.42 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA